1. Autophagy modulation in MEK inhibitor‐resistant melanoma. (1st February 2019) Authors: Verykiou, S.; Alexander, M.; Edwards, N.; Plummer, R.; Chaudhry, B.; Lovat, P.E.; Hill, D.S. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Autophagy modulation in MEK inhibitor‐resistant melanoma. (4th February 2019) Authors: Verykiou, S.; Alexander, M.; Edwards, N.; Plummer, R.; Chaudhry, B.; Lovat, P.E.; Hill, D.S. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas. (19th June 2019) Authors: Ellis, R.; Tang, D.; Nasr, B.; Greenwood, A.; McConnell, A.; Anagnostou, M.E.; Elias, M.; Verykiou, S.; Bajwa, D.; Ewen, T.; Reynolds, N.J.; Barrett, P.; Carling, E.; Watson, G.; Armstrong, J.; Allen, A.J.; Horswell, S.; Labus, M.; Lovat, P.E. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas. (1st January 2020) Authors: Ellis, R.; Tang, D.; Nasr, B.; Greenwood, A.; McConnell, A.; Anagnostou, M.E.; Elias, M.; Verykiou, S.; Bajwa, D.; Ewen, T.; Reynolds, N.J.; Barrett, P.; Carling, E.; Watson, G.; Armstrong, J.; Allen, A.J.; Horswell, S.; Labus, M.; Lovat, P.E. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Harnessing autophagy to overcome mitogen‐activated protein kinase kinase inhibitor‐induced resistance in metastatic melanoma. (1st February 2019) Authors: Verykiou, S.; Alexander, M.; Edwards, N.; Plummer, R.; Chaudhry, B.; Lovat, P.E.; Hill, D.S. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: 346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Harnessing autophagy to overcome mitogen‐activated protein kinase kinase inhibitor‐induced resistance in metastatic melanoma. (25th November 2018) Authors: Verykiou, S.; Alexander, M.; Edwards, N.; Plummer, R.; Chaudhry, B.; Lovat, P.E.; Hill, D.S. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: 346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Measuring two proteins to help assess which melanomas are most likely to spread. (1st January 2020) Authors: Ellis, R.; Tang, D.; Nasr, B.; Greenwood, A.; McConnell, A.; Anagnostou, M.E.; Elias, M.; Verykiou, S.; Bajwa, D.; Ewen, T.; Reynolds, N.J.; Barrett, P.; Carling, E.; Watson, G.; Armstrong, J.; Allen, A.J.; Horswell, S.; Labus, M.; Lovat, P.E. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Measuring two proteins to help assess which melanomas are most likely to spread. (2nd January 2020) Authors: Ellis, R.; Tang, D.; Nasr, B.; Greenwood, A.; McConnell, A.; Anagnostou, M.E.; Elias, M.; Verykiou, S.; Bajwa, D.; Ewen, T.; Reynolds, N.J.; Barrett, P.; Carling, E.; Watson, G.; Armstrong, J.; Allen, A.J.; Horswell, S.; Labus, M.; Lovat, P.E. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration. (1st April 2022) Authors: Cosgarea, I.; McConnell, A.T.; Ewen, T.; Tang, D.; Hill, D.S.; Anagnostou, M.; Elias, M.; Ellis, R.A.; Murray, A.; Spender, L.C.; Giglio, P.; Gagliardi, M.; Greenwood, A.; Piacentini, M.; Inman, G.J.; Fimia, G.M.; Corazzari, M.; Armstrong, J.L.; Lovat, P.E. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration. (27th December 2021) Authors: Cosgarea, I.; McConnell, A.T.; Ewen, T.; Tang, D.; Hill, D.S.; Anagnostou, M.; Elias, M.; Ellis, R.A.; Murray, A.; Spender, L.C.; Giglio, P.; Gagliardi, M.; Greenwood, A.; Piacentini, M.; Inman, G.J.; Fimia, G.M.; Corazzari, M.; Armstrong, J.L.; Lovat, P.E. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗